Want to see AU:ICR full AI Analyst Report?
InteliCare Holdings Limited (ICR) AI Stock Analysis
InteliCare Holdings Limited
(ASX:ICR)
The overall score reflects a speculative healthcare information services company with improving revenue growth and margins but ongoing losses and negative cash flow that pose sustainability risk, combined with a weak, near-oversold technical profile and a cautious valuation view driven by the absence of earnings and dividends.
InteliCare Holdings Limited (ICR) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 13.59M
- Dividend Yield
- ―
- Average Volume (3M)
- 532.33K
- Price to Earnings (P/E)
- -5.6
- Beta (1Y)
- 0.25
- Revenue Growth
- 113.42%
- EPS Growth
- 29.17%
- Country
- Australia
- Employees
- 8
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
InteliCare Holdings Limited Business Overview & Revenue Model
Company Description
Operating out of Leederville, Australia, Intelicare Holdings Limited was founded in 2016. The company is dedicated to supplying innovative predictive analytics solutions, delivered as a combined hardware and software package, primarily serving Austra...
InteliCare Holdings Limited Financial Statement Overview
Summary
Strong recent revenue growth and improving margins are offset by continued operating and net losses, a historically fragile balance sheet, and persistently negative operating and free cash flow, leaving the business still clearly loss-making and cash-burning.
Income Statement
52NeutralBalance Sheet
46NeutralCash Flow
38Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.04M | 2.04M | 956.74K | 280.29K | 404.35K | 429.85K |
| Gross Profit | -1.12M | -1.12M | -1.09M | -1.79M | -2.69M | -2.75M |
| EBITDA | -2.46M | -2.45M | -2.07M | -3.02M | -2.89M | -3.78M |
| Net Income | -2.10M | -2.10M | -2.24M | -2.26M | -3.00M | -3.93M |
Balance Sheet | ||||||
| Total Assets | 3.34M | 3.34M | 1.02M | 1.52M | 2.48M | 2.88M |
| Cash, Cash Equivalents and Short-Term Investments | 2.73M | 2.73M | 410.53K | 834.20K | 1.94M | 2.27M |
| Total Debt | 524.82K | 524.82K | 716.62K | 612.39K | 726.57K | 18.25K |
| Total Liabilities | 2.11M | 2.11M | 1.86M | 1.69M | 1.53M | 1.34M |
| Stockholders Equity | 1.23M | 1.23M | -833.17K | -168.32K | 949.11K | 1.54M |
Cash Flow | ||||||
| Free Cash Flow | -1.19M | -1.19M | -1.67M | -1.66M | -3.11M | -3.14M |
| Operating Cash Flow | -1.18M | -1.18M | -1.67M | -1.66M | -3.10M | -3.10M |
| Investing Cash Flow | -3,814 | -3,814 | -7,094 | 0 | -14.35K | -32.92K |
| Financing Cash Flow | 3.51M | 3.51M | 1.25M | 555.65K | 2.78M | 2.73M |
InteliCare Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ICR, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 30.69 is Neutral, neither overbought nor oversold. The STOCH value of 11.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ICR.
InteliCare Holdings Limited Peers Comparison
Overall Rating
AU:ALC63Neutral
AU:DOC52Neutral
AU:ONE48Neutral
AU:BMT45Neutral- AU:ICR43Neutral
AU:PCK38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AU:ALC | 63Neutral | AUD 148.48M | 64.70 | 2.53% | ― | 26.61% | 41.67% |
| AU:DOC | 52Neutral | AUD 38.50M | 14.50 | 90.90% | ― | 5.35% | ― |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| AU:ONE | 48Neutral | AUD 109.10M | -6.35 | -203.69% | ― | -1.53% | 28.29% |
| AU:BMT | 45Neutral | AUD 21.26M | -1.02 | -58.13% | ― | 2.08% | -195.31% |
| AU:ICR | 43Neutral | AUD 14.31M | -5.59 | -416.53% | ― | 113.42% | 29.17% |
| AU:PCK | 38Underperform | AUD 16.32M | -1.73 | -1688.04% | ― | 11.45% | 0.69% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:ICR | InteliCare Holdings Limited | 0.02 | 0.00 | 11.11% | |
| AU:ONE | Oneview Healthcare PLC Chess Depository Interests repr 1 | 0.13 | -0.06 | -31.58% | |
| AU:BMT | Beamtree Holdings Ltd | 0.07 | -0.13 | -64.50% | |
| AU:ALC | Alcidion Group Limited | 0.10 | 0.01 | 16.67% | |
| AU:PCK | PainChek Ltd | 0.07 | -0.39 | -85.43% | |
| AU:DOC | Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh | 0.10 | -0.04 | -31.03% |
InteliCare Holdings Limited Corporate Events
InteliCare expands aged care deployments and builds SaaS revenue base
InteliCare used the September 2026 quarter to deepen deployments with existing partners mecwacare, Hardi Aged Care and Warrigal Care, concentrating on residential aged care rollouts and preparing its first retirement living deployment. The company is...
InteliCare Posts Quarterly Cash Outflow Amid Stable Customer Receipts
InteliCare reported customer receipts of A$408,000 for the quarter ended 30 September 2026, reflecting ongoing commercial activity in its smart care and monitoring solutions.Operating cash outflows totalled A$1.27 million, driven by product manufactu...
InteliCare Sets 2026 AGM to Review Reports and Board Composition
InteliCare Holdings Limited has called its 2026 Annual General Meeting for 10.00am AWST on 25 November 2026 in Leederville, Western Australia, setting Monday 23 November 2026 as the record date for shareholder voting eligibility. The notice confirms...
InteliCare Files 2026 Annual Report and Confirms ASX Compliance
InteliCare Holdings Limited released its annual report for the year ended 30 June 2026, detailing its corporate structure, governance arrangements and key professional advisers. The document confirms the company’s continued ASX listing, outline...
InteliCare lodges updated ASX corporate governance statement for FY26
InteliCare Holdings has released its latest corporate governance statement for the financial year ended 30 June 2026, confirming it is available via the investor section of the company’s website. The statement, approved by the board as at 14 Oc...
InteliCare Sets 2026 AGM Date and Director Nomination Deadline
InteliCare Holdings Ltd, an Australian technology firm, develops predictive analytics systems integrating smart sensors and artificial intelligence to support aged care and health providers. Its internet of things platform underpins both business-to-...
InteliCare Narrows Annual Loss and Turns Net Tangible Assets Positive
InteliCare Holdings Limited reported a reduced annual loss for the year ended 30 June 2026, with loss from ordinary activities after tax narrowing 6.5% to $2.10 million compared with the prior year. The company did not declare any dividends, and its...
InteliCare Says No Undisclosed News Behind Share Price Spike
InteliCare Holdings Ltd has responded to an Australian Securities Exchange price and volume query after its shares rose from $0.024 to an intraday high of $0.028 amid heavier trading. The company stated it is not aware of any undisclosed information...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 15, 2026